Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great news Coach. I'm on Amlodipine!
Do you mean recovered more easily if infected with covid?
Right on Mike. Thanks for the review of the agreement. If interested, send me a request to join Dharma Lovers on FB, for the real stuff.
Back above the 200 day. Decent volume too.
Thanks for posting Mike. Gonna be a bit of a wait.
Letting a computer randomize you to either on or off the drug is akin to letting a computer decide whether you have a strong chance of living or dying. There is a huge body of evidence of your survival chances off lero. Nobody should have to play this Russian roulette.
I think such a call would get pre-screened out, but haven't tried it.
Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s Disease
https://www.cassavasciences.com/news-releases/news-release-details/cassava-sciences-announces-initiation-open-label-study-evaluate
Looks good to me Mike!
Extra office space available on the same floor if needed for expansion.
I'm down in Portland, with Vancouver just across the river, was going to do a Cytodyn drive-by, but this was easier:
insert-text-here Click on link for photo.
This sort of informal contact can lead to misinformed or misleading statements. I say just let it be tried in China first, where litiginous lawyers are not prowling.
Try E-trade.
Great link Mike. Thanks for posting it.
Found this on Nextdoor, Washington Co, Oregon. Claims near development in Israel of both a vaccine against corona, and also a "cure for all cancers":
https://www.dailywire.com/news/bds-this-israel-makes-exciting-breakthrough-in-race-for-coronavirus-vaccine
From another board:
I thought there were more than 2 improved biomarkers?
Last patient in current study should get his/her final dose end of Feb. Need some news to get us out of this current channel. This PR dated 01/28.
Why isn't this sticked? Excellent synopsis.
Thanks. I know the DOD is sponsoring some breast CA studies. I thought that might be a source.
Another topic for the bio guys: Any evidence this might work on hematologic malignancies?
Where would non-dilutive come from? NIH?
In the TYME and SAVA boat with you Mike, but still above H2O.
My CYDY however, ain't looking too bad.
Your chart lied!
Good move Mike. Likewise for me.
Clever guy, working both ends of the equation!
Yes, thanks!
Mike, refresh my memory...when did LineaRX go from being a "wholly owned subsidiary" to a "majority owned subsidiary"? And how much was divested and to whom?
Yes, liked the SA article. But don't understand how these articles are generated. Picked up quite a few more shares at 1.61 yesterday.
Loved the news! Very strong impetus to get moving to market, or for an even bigger bio to gobble both up.
I'm sure I'm in the minority here, owning 2 mil shares and well above water, in saying that I wouldn't mind a bit if they did a R/S at 1 for 10. A SP of .7 or so and a OS of 100 mil would look a lot more appealing to many investors, and make for a bit more competition among buyers. Correct me if my numbers are way off.
Had never heard of Eagle. Sounds like a solid company. Here's a few points from a recent presentation of their's:
The Eagle Story: Building from Our Successes
Two significant initial successes: bendamustine and RYANODEX®
From 2015-YTD2019: generated approximately $250 mm in cash flow from
operations* creating substantial profitability
Efficient business model and successful cash re-investment:
? Share repurchase: bought back $169 mm, or 17%, vs. $110 mm issued; only
13.7 million basic shares outstanding
? Invested 20%+ of revenue in non-GAAP Research & Development
Healthy balance sheet: no net debt and ability to deploy capital for inlicensing/acquisitions
Significant near-term pipeline: focus on best-in-class oncology and critical care
(including medical countermeasures against terrorism)
• RYANODEX for brain damage secondary to Nerve Agent (NA) Exposure, Acute
Radiation Syndrome (ARS) and Exertional Heat Stroke (EHS)
• Fulvestrant, PEMFEXY™
• Anticipate important news flow over the next six months
Looks like you got caught by this turd!
I've asked more or less the same question since I bought in last September. Does improving the biomarkers actually improve mentation? Or has the damage already been done? If it doesn't restore function, can it be used as a prophylactic, still making it a bil$ drug? Guess we have to wait for P3.
Fair enough. Hope they don't want to wait for CTAD to present. With a twice a day pill, pre and post dosing blood test, and no mental/functional patient testing, how difficult will it be to find 60 or so mild to mod AZ patients? Particularly with NIH backing.
How do you figure? 2b is only a 28 day study.
Not questioning your trading methodology. Just pointing out that you reposted wrong info posted by jimmy667.
Suggest you read biobonic's posts from yesterday. Particularly post 1252.